Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Moeve to invest €600m in 30 biomethane production plants in Spain Moeve has unveiled a €600 million investment plan to develop 30 biomethane production plants across Spain by 2030,… byPallavi MadhirajuFebruary 1, 2025